{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:19:55Z","timestamp":1790713195850,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T00:00:00Z","timestamp":1534377600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00345-018-2442-0","type":"journal-article","created":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T09:18:51Z","timestamp":1534411131000},"page":"261-268","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Extra-target low-risk prostate cancer: implications for focal high-intensity focused ultrasound of clinically significant prostate cancer"],"prefix":"10.1007","volume":"37","author":[{"given":"A.","family":"Annoot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Valtille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Deken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Puech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Villers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,16]]},"reference":[{"issue":"4","key":"2442_CR1","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","volume":"71","author":"N Mottet","year":"2017","unstructured":"Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M et al (2017) EAU-ESTRO-SIOG guidelines on prostate cancer. Part 1: Screening, diagnosis, and local treatment with curative intent. Eur Urol 71(4):618\u2013629","journal-title":"Eur Urol"},{"issue":"5","key":"2442_CR2","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1056\/NEJMoa1209978","volume":"368","author":"MJ Resnick","year":"2013","unstructured":"Resnick MJ, Koyama T, Fan K-H, Albertsen PC, Goodman M, Hamilton AS et al (2013) Long-term functional outcomes after treatment for localized prostate cancer. N Engl J Med 368(5):436\u2013445","journal-title":"N Engl J Med"},{"issue":"1","key":"2442_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.eururo.2016.08.044","volume":"71","author":"M Valerio","year":"2017","unstructured":"Valerio M, Cerantola Y, Eggener SE, Lepor H, Polascik TJ, Villers A et al (2017) New and established technology in focal ablation of the prostate: a systematic review. Eur Urol 71(1):17\u201334","journal-title":"Eur Urol"},{"issue":"4","key":"2442_CR4","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.eururo.2014.09.018","volume":"67","author":"IA Donaldson","year":"2015","unstructured":"Donaldson IA, Alonzi R, Barratt D, Barret E, Berge V, Bott S et al (2015) Focal therapy: patients, interventions, and outcomes\u2014a report from a consensus meeting. Eur Urol 67(4):771\u2013777","journal-title":"Eur Urol"},{"issue":"4","key":"2442_CR5","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/j.1464-410X.2011.10776.x","volume":"110","author":"P Nevoux","year":"2011","unstructured":"Nevoux P, Ouzzane A, Ahmed HU, Emberton M, Montironi R, Presti JC Jr et al (2011) Quantitative tissue analyses of prostate cancer foci in an unselected cystoprostatectomy series. BJU Int 110(4):517\u2013523","journal-title":"BJU Int"},{"issue":"6","key":"2442_CR6","doi-asserted-by":"publisher","first-page":"2203","DOI":"10.1016\/j.juro.2008.01.114","volume":"179","author":"GS Yoon","year":"2008","unstructured":"Yoon GS, Wang W, Osunkoya AO, Lane Z, Partin AW, Epstein JI (2008) Residual tumor potentially left behind after local ablation therapy in prostate adenocarcinoma. J Urol 179(6):2203\u20132206","journal-title":"J Urol"},{"issue":"9","key":"2442_CR7","doi-asserted-by":"publisher","first-page":"2313","DOI":"10.1002\/1097-0142(19921101)70:9<2313::AID-CNCR2820700917>3.0.CO;2-T","volume":"70","author":"A Villers","year":"1992","unstructured":"Villers A, McNeal JE, Freiha FS, Stamey TA (1992) Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors. Cancer 70(9):2313\u20132318","journal-title":"Cancer"},{"issue":"5","key":"2442_CR8","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nm.1944","volume":"15","author":"W Liu","year":"2009","unstructured":"Liu W, Laitinen S, Khan S, Vihinen M, Kowalski J, Yu G et al (2009) Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer. Nat Med 15(5):559\u2013565","journal-title":"Nat Med"},{"issue":"17","key":"2442_CR9","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1056\/NEJMcibr0905562","volume":"361","author":"HU Ahmed","year":"2009","unstructured":"Ahmed HU et al (2009) The index lesion and the origin of prostate cancer. N Engl J Med 361(17):1704","journal-title":"N Engl J Med"},{"issue":"1","key":"2442_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/pcan.2010.16","volume":"14","author":"M Karavitakis","year":"2011","unstructured":"Karavitakis M, Winkler M, Abel P, Livni N, Beckley I, Ahmed HU (2011) Histological characteristics of the index lesion in whole-mount radical prostatectomy specimens: implications for focal therapy. Prostate Cancer Prostatic Dis 14(1):46\u201352","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"2442_CR11","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00428-014-1557-y","volume":"464","author":"CC Huang","year":"2014","unstructured":"Huang CC, Deng F-M, Kong MX, Ren Q, Melamed J, Zhou M (2014) Re-evaluating the concept of \u201cdominant\/index tumor nodule\u201d in multifocal prostate cancer. Virchows Arch 464(5):589\u2013594","journal-title":"Virchows Arch"},{"issue":"11","key":"2442_CR12","doi-asserted-by":"publisher","first-page":"2362","DOI":"10.1002\/cncr.20243","volume":"100","author":"R Arora","year":"2004","unstructured":"Arora R, Koch MO, Eble JN, Ulbright TM, Li L, Cheng L (2004) Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate. Cancer. 100(11):2362\u20132366","journal-title":"Cancer."},{"issue":"3","key":"2442_CR13","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1200\/JCO.2014.55.1192","volume":"33","author":"L Klotz","year":"2015","unstructured":"Klotz L, Vesprini D, Sethukavalan P, Jethava V, Zhang L, Jain S et al (2015) Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol 33(3):272\u2013277","journal-title":"J Clin Oncol"},{"issue":"2","key":"2442_CR14","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.eururo.2016.09.039","volume":"71","author":"P Rischmann","year":"2017","unstructured":"Rischmann P, Gelet A, Riche B, Villers A, Pasticier G, Bondil P et al (2017) Focal high intensity focused ultrasound of unilateral localized prostate cancer: a prospective multicentric hemiablation study of 111 patients. Eur Urol 71(2):267\u2013273","journal-title":"Eur Urol"},{"issue":"3","key":"2442_CR15","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/pcan.2017.8","volume":"20","author":"KJ Tay","year":"2017","unstructured":"Tay KJ, Scheltema MJ, Ahmed HU, Barret E, Coleman JA, Dominguez-Escrig J et al (2017) Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project. Prostate Cancer Prostatic Dis 20(3):294\u2013299","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"5","key":"2442_CR16","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.eururo.2013.04.039","volume":"65","author":"S Crouzet","year":"2014","unstructured":"Crouzet S, Chapelon JY, Rouvi\u00e8re O, Mege-Lechevallier F, Colombel M, Tonoli-Catez H et al (2014) Whole-gland ablation of localized prostate cancer with high-intensity focused ultrasound: oncologic outcomes and morbidity in 1002 patients. Eur Urol 65(5):907\u2013914","journal-title":"Eur Urol"},{"issue":"3","key":"2442_CR17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/jjco\/hym173","volume":"38","author":"S Muto","year":"2008","unstructured":"Muto S, Yoshii T, Saito K, Kamiyama Y, Ide H, Horie S (2008) Focal therapy with high-intensity-focused ultrasound in the treatment of localized prostate cancer. Jpn J Clin Oncol 38(3):192\u2013199","journal-title":"Jpn J Clin Oncol"},{"issue":"6","key":"2442_CR18","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S1470-2045(12)70121-3","volume":"13","author":"HU Ahmed","year":"2012","unstructured":"Ahmed HU, Hindley RG, Dickinson L, Freeman A, Kirkham AP, Sahu M et al (2012) Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study. Lancet Oncol 13(6):622\u2013632","journal-title":"Lancet Oncol"},{"key":"2442_CR19","first-page":"1","volume":"2014","author":"R Velthoven Van","year":"2014","unstructured":"Van Velthoven R, Aoun F, Limani K, Narahari K, Lemort M, Peltier A (2014) Primary zonal high intensity focused ultrasound for prostate cancer: results of a prospective phase iia feasibility study. Prostate Cancer 2014:1\u20136","journal-title":"Prostate Cancer"},{"issue":"6","key":"2442_CR20","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.eururo.2015.01.030","volume":"68","author":"HU Ahmed","year":"2015","unstructured":"Ahmed HU, Dickinson L, Charman S, Weir S, McCartan N, Hindley RG et al (2015) Focal ablation targeted to the index lesion in multifocal localised prostate cancer: a prospective development study. Eur Urol 68(6):927\u2013936","journal-title":"Eur Urol"},{"issue":"2","key":"2442_CR21","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.eururo.2015.06.018","volume":"69","author":"ERC Feijoo","year":"2016","unstructured":"Feijoo ERC, Sivaraman A, Barret E, Sanchez-Salas R, Galiano M, Rozet F et al (2016) Focal high-intensity focused ultrasound targeted hemiablation for unilateral prostate cancer: a prospective evaluation of oncologic and functional outcomes. Eur Urol 69(2):214\u2013220","journal-title":"Eur Urol"},{"issue":"2","key":"2442_CR22","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1590\/S1677-55382011000200008","volume":"37","author":"ABE Fegoun","year":"2011","unstructured":"Fegoun ABE, Barret E, Prapotnich D, Soon S, Cathelineau X, Rozet F et al (2011) Focal therapy with high-intensity focused ultrasound for prostate cancer in the elderly: a feasibility study with 10\u00a0years follow-up. Int Braz J Urol 37(2):213\u2013222","journal-title":"Int Braz J Urol"},{"issue":"4","key":"2442_CR23","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.juro.2017.10.033","volume":"199","author":"R Ganzer","year":"2018","unstructured":"Ganzer R, Hadaschik B, Pahernik S, Koch D, Baumunk D, Kuru T et al (2018) Prospective multicenter phase II study on focal therapy (hemiablation) of the prostate with high intensity focused ultrasound. J Urol 199(4):983\u2013989","journal-title":"J Urol"},{"key":"2442_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2018.06.006","author":"S Guillaumier","year":"2018","unstructured":"Guillaumier S, Peters M, Arya M, Afzal N, Charman S, Dudderidge T et al (2018) A multicentre study of 5-year outcomes following focal therapy in treating clinically significant nonmetastatic prostate cancer. Eur Urol. \n                    https:\/\/doi.org\/10.1016\/j.eururo.2018.06.006","journal-title":"Eur Urol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-018-2442-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-018-2442-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-018-2442-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,15]],"date-time":"2019-08-15T23:07:34Z","timestamp":1565910454000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-018-2442-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,16]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["2442"],"URL":"https:\/\/doi.org\/10.1007\/s00345-018-2442-0","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,16]]},"assertion":[{"value":"5 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"For this type of study formal consent is not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Formal consent"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}